According to Custom Market Insights (CMI), The global Thoracic Drainage Devices market was estimated at USD 570 million and is anticipated to reach around USD 900 million by 2030, growing at a CAGR of roughly 5% between 2022 and 2030. Our research report offers a 360-degree view of the Thoracic Drainage Devices market’s drivers and restraints, coupled with their impact on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Thoracic Drainage Devices market.
Thoracic Drainage DevicesMarket: Overview
A flexible plastic tube known as a thoracic drainage device, sometimes a chest pipe, is placed through the thoracic cavity and into the mediastinum or pleural area. The three chambers of a three-bottle system are most frequently used in drainage systems. The first chamber collects the chest fluid, while the second chamber serves as a water seal and acts as a one-way valve that lets gas out but prevents it from coming back in.
The third bottle is used to drain fluid, including pleural effusion, blood flow, or pulse, when empyema originates from the intrathoracic spaces or air, in the case of pneumothorax. These devices are comfortable, secure, and well-tolerated while the patients’ thoracic drainage is removed. Quick drainage pullout capabilities enable it to lower or eliminate hospital stay costs.
Browse the full “Thoracic Drainage Devices Market Size, Trends and Insights By Product (Pleural Drainage Catheters, Thoracic Drainage Kits, Secured Needles, Thoracic Drainage Systems, Others), By Application (Thoracic Surgery & Pulmonology, Cardiac Surgery, Infectious Diseases, General Intensive Care Emergency Medicine, Oncology and Pain Management, Others), By End-user (Hospitals and Clinics, Ambulatory Surgery Centers, Ambulance Services, Military Surgeons, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030” report at ReportURL
Growth Factors
Thoracic drainage device sales are growing due to rising demand for minimally invasive surgery, the incidence of cardiovascular disorders, and the burden of spontaneous pneumothoraxes. Increased desire for minimally invasive surgeries over more standard procedures is causing the rapid growth pace.
In addition to having significant advantages like a lower risk of complications, shorter hospital stays, and quicker recovery, these techniques frequently produce outcomes comparable to those of traditional open surgery. A key reason for the increase in demand for minimally invasive surgery compared to standard surgical techniques was the reduction of the associated treatment costs.
Segmental Overview
The market for Thoracic Drainage Devices is segmented into product, application, and end-user. Based on application, the market for the cardiac surgery segment is anticipated to exhibit a high CAGR during 2022-2030. Pleural effusions are relatively prevalent, with around 100,000 cases being identified in the United States each year, according to the National Cancer Institute.
India has one of the world’s highest rates of open-heart surgeries, with around 200,000 performed there each year, according to the Press Information Bureau. Traumatic pneumothorax also occurs more frequently in cases of physical trauma to the chest brought on by complications with medical interventions. Thoracic diseases become more prevalent as a result of this. Airways, chest wall, lungs, intercostal muscles, diaphragm, and neurological connections are among the respiratory system’s components vulnerable to harm from numerous cardiac surgeries and CPB-related processes.
Regional Overview
During 2022-2030, North America is expected to be a very appealing market for thoracic drainage devices. In 2021, the region held the biggest market share worldwide. The rise in pleural effusion and pneumothorax cases in the United States has placed a significant financial strain on the federal government and increased demand for additional medical facilities and therapies. Pneumothorax research has revealed that the incidence of primary spontaneous pneumothorax (PSP) in men in the United States is approximately 7.4 per 100,000 per year. Moreover, 1.5 million patients in the U.S. undergo almost 178,000 thoracenteses with pleural effusion annually.
From 2022 to 2030, Europe’s market is anticipated to expand steadily. The availability of clearly defined reimbursement policies from public and commercial health insurance companies, along with the highly structured nature of the healthcare sector, is likely to drive the market for thoracic drainage devices in the area. The market in the Asia Pacific is predicted to expand quickly during the forecast period due to the rise in demand for cutting-edge medical technology in developing nations like China and India.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 570 million |
| Projected Market Size in 2030 | USD 900 million |
| CAGR Growth Rate | 5% CAGR |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Prominent Players | Medtronic PLC, ATMOS MedizinTechnik GmbH & Co. KG., Cook Group Inc., BARD A Becton, Dickinson Company, Maquet Holding B.V. & Co. KG, Sinapi Biomedical, Medela Inc., Teleflex Inc., Smiths Medical, Utah Medical Products Inc., Vygon SA, and Others |
| Key Segment | By Product, Application, End-user, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors, and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfill your requirements for research. |
Competitive Landscape/Key Players Insights
The Thoracic Drainage Devices market players are focused on collaborations and joint ventures to expand their product portfolio, gain new customers, and expand their geographical reach.
Some of the prominent players
- Medtronic PLC
- ATMOS MedizinTechnik GmbH & Co., KG.
- Cook Group, Inc.
- BARD, A Becton, Dickinson Company
- Maquet Holding B.V. & Co. KG
- Sinapi Biomedical
- Medela, Inc.
- Teleflex Inc.
- Smiths Medical
- Utah Medical Products, Inc.
- Vygon SA
The global Thoracic Drainage Devices market is segmented as follows:
By Product
- Pleural Drainage Catheters
- Thoracic Drainage Kits
- Secured Needles
- Thoracic Drainage Systems
- Others
By Application
- Thoracic Surgery & Pulmonology
- Cardiac Surgery
- Infectious Diseases
- General Intensive Care Emergency Medicine
- Oncology and Pain Management
- Others
By End-user
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Ambulance Services
- Military Surgeons
- Others
By Region
North America
- The U.S.
- Canada
- Mexico
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America